Risks with Cytoreductive Therapy

Laura C. Michaelis, MD

Video Categories: Polycythemia Vera

Hear Dr. Michaelis discuss cytoreductive therapy and the risk factor for patients with hemorrhage.

Supported through funding from Incyte
March 31, 2015

Integrating Cost into Treatment

According to Alexander Bastian, it’s very difficult to determine how to integrate cost into the equation of cancer care. He explains that cost should be considered early on and uses Dr. Zafar’s term of financial toxicity, meaning the burden of cost can be as bad or worse than a physical [ Read More ]

November 24, 2014

Patients Understanding their Cancer and Treatment Options

Gary Palmer, MD, discusses the importance of patients knowing the DNA drivers of their cancer to slow the growth of their cancer.